KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
No Result
View All Result
Home Coronavirus

Osang Healthcare Receives FDA Approval for COVID-19 Detection Kit

James Jung by James Jung
PUBLISHED: April 20, 2020 UPDATED: April 20, 2020
in Coronavirus, Healthcare, Osang Healthcare, South Korea, U.S., U.S. Food and Drug Administration, Virus
0
osang healthcare genefinder covid 19 kit
Osang Healthcare receives EUA from U.S. FDA for its GeneFinder COVID-19 Plus Real Amp Kit. / photo courtesy of Osang Healthcare

Osang Healthcare receives EUA from U.S. FDA for its GeneFinder COVID-19 Plus Real Amp Kit. / photo courtesy of Osang Healthcare

Osang Healthcare announced that it received approval from the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA) for its COVID-19 RT-PCR detection kit. With the EUA, the kit would become the first FDA-approved Korean COVID-19 kit to be utilized across the U.S.

Last Saturday, the FDA issued an EUA for Osang Healthcare’s GeneFinder COVID-19 Plus Real Amp Kit. The approval notice came after a reply to the agency to correct a labeling phrase. The administration posted the approval for the kit on its website.

Osang’s GeneFinder is a qualitative test for the detection of nucleic acid from SARS-CoV-2 in the upper and lower respiratory specimens. The virus’s nucleic acid is generally detectable during the acute phase of infection.

The COVID-19 kit detects coronavirus infection using real-time reverse transcription-polymerase chain reaction (RT-PCR), a molecular diagnostic method. The diagnostic kit determines three types of genes, the RdRp gene, the E gene, and the N gene.

The FDA’s approval came 45 days after Osang Healthcare applied for an EUA early next month. The South Korean company’s product is the 41st COVID-29 diagnostic kit to be approved by the FDA for emergency use. Osang is also the first among domestic detection kit manufacturers to apply for the U.S. agency’s EUA last March.

The Korean Ministry of Food and Drug Safety approved Osang’s GeneFinder COVID-19 Plus RealAmp in mid-March. Osang Healthcare also received European certification (CE-IVD) for its product last February.

The company said it now sells its product in over 100 countries worldwide.

FEMA Agreement

Before acquiring the FDA’s approval, Osang Healthcare said it recently agreed with the U.S. Federal Emergency Management Agency (FEMA) as a supplier of testing kits worth $3 million (3.66 billion won). The agreement would ramp up the federal government’s strategic stockpile.

The FEMA deal became possible due to the FDA allowing testing laboratories with a Clinical Laboratory Improvement Amendments (CLIA) certification to import COVID-19 detection kits even if the products were in the FDA’s review stage.

Osang added that the agreement with FEMA would bump up the capacity to meet increased demand from Latin America, the Middle East, and Europe after the clearance from the FDA.

South Korea’s Ministry of Foreign Affairs (MOFA) said that three local companies, which include Osang Healthcare, received FDA’s EUA for their detection kits late March. However, the other two companies have yet to obtain results.

Osang Healthcare, founded in 1996, specializes in the development of diagnostic devices, such as glycated hemoglobin and cholesterol measuring devices, immune/molecular diagnostics devices, and blood sugar checkers. The company exports its products to over 110 countries.

Tags: approvalcoronavirusCOVID-19diagnostic kitEUAFDAFEMAGeneFinderkitOsangSARS-CoV-2South Korea newsU.S.

Related Posts

Korea’s APEC Digital & AI Forum Highlights Asia’s Push for Responsible Tech Leadership
Osang Healthcare receives EUA from U.S. FDA for its GeneFinder COVID-19 Plus Real Amp Kit. / photo courtesy of Osang Healthcare
South Korea

Korea’s APEC Digital & AI Forum Highlights Asia’s Push for Responsible Tech Leadership

October 24, 2025
LG Uplus Bows to Pressure, Will Report Hacking Signs to Cybersecurity Watchdog
Osang Healthcare receives EUA from U.S. FDA for its GeneFinder COVID-19 Plus Real Amp Kit. / photo courtesy of Osang Healthcare
LG

LG Uplus Bows to Pressure, Will Report Hacking Signs to Cybersecurity Watchdog

October 22, 2025
South Korea Tightens Cyber Defenses After Detecting Government Hacking Attempt
Osang Healthcare receives EUA from U.S. FDA for its GeneFinder COVID-19 Plus Real Amp Kit. / photo courtesy of Osang Healthcare
Government

South Korea Tightens Cyber Defenses After Detecting Government Hacking Attempt

October 21, 2025
When Data Fails Trust: A Deep Dive into South Korea’s Escalating Breach Crisis
Osang Healthcare receives EUA from U.S. FDA for its GeneFinder COVID-19 Plus Real Amp Kit. / photo courtesy of Osang Healthcare
Editorial Feature

When Data Fails Trust: A Deep Dive into South Korea’s Escalating Breach Crisis

October 17, 2025
South Korea, BlackRock Team Up to Build Hyperscale AI Data Center Hub
Osang Healthcare receives EUA from U.S. FDA for its GeneFinder COVID-19 Plus Real Amp Kit. / photo courtesy of Osang Healthcare
Data Center

South Korea, BlackRock Team Up to Build Hyperscale AI Data Center Hub

October 1, 2025
Global API Standardization Gets a Push with SK Telecom–Aduna Partnership
Osang Healthcare receives EUA from U.S. FDA for its GeneFinder COVID-19 Plus Real Amp Kit. / photo courtesy of Osang Healthcare
AI

Global API Standardization Gets a Push with SK Telecom–Aduna Partnership

September 23, 2025
No Result
View All Result

Most Popular

  • Ride-Hailing Rivalry: Kakao and Uber Bet on Membership Services in Korea

    0 shares
    Share 0 Tweet 0
  • Kakao Mobility Faces $10.5 Million Fine for Limiting Competitors’ Access to Taxi Platform

    0 shares
    Share 0 Tweet 0
  • Korea’s Navigation Battle Heats Up: Naver and Kakao vs. Google maps

    0 shares
    Share 0 Tweet 0
  • 5 Best Korean to English Translation Apps

    0 shares
    Share 0 Tweet 0
  • Naver Maps Launches Guide in English, Chinese, and Japanese to Enhance Travel Experience for Tourists

    0 shares
    Share 0 Tweet 0
  • Naver Unveils Asia’s Largest Data Center, GAK Sejong, for Tech Innovation

    0 shares
    Share 0 Tweet 0
  • Naver Video Streaming Service V Live to Go Global

    0 shares
    Share 0 Tweet 0
  • What SK Group’s ‘AI Now & Next’ Summit Reveals About the Future of Intelligent Korea

    0 shares
    Share 0 Tweet 0
  • South Korea’s $2.26 Billion Vision: A Robotic Revolution by 2030

    0 shares
    Share 0 Tweet 0
  • Hanwha Aerospace to Develop Indigenous Turboprop Engine for South Korea’s Next-Gen UAVs

    0 shares
    Share 0 Tweet 0

PRODUCTS

[ads_amazon]

TOPICS

  • Naver
  • Kakao
  • Nexon
  • Netmarble
  • NCsoft
  • Samsung
  • Hyundai

FREE NEWSLETTER

FOLLOW US

  • About Us
  • Cookie policy
  • home
  • homepage
  • mainhome
  • Our Services
  • Privacy Policy
  • Terms of Use

Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : [email protected] |

No Result
View All Result
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists

Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : [email protected] |